VYNE Therapeutics Inc.

NasdaqCM:VYNE 주식 보고서

시가총액: US$28.6m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

VYNE Therapeutics 관리

관리 기준 확인 2/4

VYNE Therapeutics' CEO는 Dave Domzalski, Mar2020 에 임명되었습니다 의 임기는 4.25 년입니다. 총 연간 보상은 $ 2.72M, 23.5% 로 구성됩니다. 23.5% 급여 및 76.5% 보너스(회사 주식 및 옵션 포함). 는 $ 1.10M 가치에 해당하는 회사 주식의 3.43% 직접 소유합니다. 1.10M. 경영진과 이사회의 평균 재임 기간은 각각 4.3 년과 3.2 년입니다.

주요 정보

Dave Domzalski

최고 경영자

US$2.7m

총 보상

CEO 급여 비율23.5%
CEO 임기4.3yrs
CEO 소유권3.4%
경영진 평균 재임 기간4.3yrs
이사회 평균 재임 기간3.2yrs

최근 관리 업데이트

Recent updates

Here's Why We're Watching VYNE Therapeutics' (NASDAQ:VYNE) Cash Burn Situation

Apr 27
Here's Why We're Watching VYNE Therapeutics' (NASDAQ:VYNE) Cash Burn Situation

We're Keeping An Eye On VYNE Therapeutics' (NASDAQ:VYNE) Cash Burn Rate

May 04
We're Keeping An Eye On VYNE Therapeutics' (NASDAQ:VYNE) Cash Burn Rate

VYNE Therapeutics Non-GAAP EPS of -$0.13 beats by $0.02, revenue of $0.13M beats by $0.03M

Aug 12

Companies Like VYNE Therapeutics (NASDAQ:VYNE) Could Be Quite Risky

Jul 02
Companies Like VYNE Therapeutics (NASDAQ:VYNE) Could Be Quite Risky

VYNE Therapeutics (NASDAQ:VYNE) Will Have To Spend Its Cash Wisely

Mar 19
VYNE Therapeutics (NASDAQ:VYNE) Will Have To Spend Its Cash Wisely

VYNE Therapeutics: Lots Of Clinical Risk Ahead And A Questionable Business Plan

Jan 13

VYNE Therapeutics (NASDAQ:VYNE) Will Have To Spend Its Cash Wisely

Dec 03
VYNE Therapeutics (NASDAQ:VYNE) Will Have To Spend Its Cash Wisely

Newsflash: VYNE Therapeutics Inc. (NASDAQ:VYNE) Analysts Have Been Trimming Their Revenue Forecasts

Aug 13
Newsflash: VYNE Therapeutics Inc. (NASDAQ:VYNE) Analysts Have Been Trimming Their Revenue Forecasts

VYNE Therapeutics: Terrible Depreciation Of Shareholder Value

Jun 30

Despite Lacking Profits VYNE Therapeutics (NASDAQ:VYNE) Seems To Be On Top Of Its Debt

Jun 07
Despite Lacking Profits VYNE Therapeutics (NASDAQ:VYNE) Seems To Be On Top Of Its Debt

Newsflash: VYNE Therapeutics Inc. (NASDAQ:VYNE) Analysts Have Been Trimming Their Revenue Forecasts

Feb 17
Newsflash: VYNE Therapeutics Inc. (NASDAQ:VYNE) Analysts Have Been Trimming Their Revenue Forecasts

Breakeven On The Horizon For VYNE Therapeutics Inc. (NASDAQ:VYNE)

Feb 10
Breakeven On The Horizon For VYNE Therapeutics Inc. (NASDAQ:VYNE)

VYNE Therapeutics closes capital raise of $50M

Jan 29

What Is The Ownership Structure Like For VYNE Therapeutics Inc. (NASDAQ:VYNE)?

Jan 06
What Is The Ownership Structure Like For VYNE Therapeutics Inc. (NASDAQ:VYNE)?

VYNE Therapeutics reports successful FDA meeting for FCD105 in acne

Dec 17

CEO 보상 분석

Dave Domzalski 의 보수는 VYNE Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$29m

Dec 31 2023US$3mUS$638k

-US$28m

Sep 30 2023n/an/a

-US$29m

Jun 30 2023n/an/a

-US$33m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$1mUS$638k

-US$34m

Sep 30 2022n/an/a

-US$35m

Jun 30 2022n/an/a

-US$40m

Mar 31 2022n/an/a

-US$42m

Dec 31 2021US$5mUS$638k

-US$44m

Sep 30 2021n/an/a

-US$59m

Jun 30 2021n/an/a

-US$69m

Mar 31 2021n/an/a

-US$226m

Dec 31 2020US$3mUS$501k

-US$256m

Sep 30 2020n/an/a

-US$270m

Jun 30 2020n/an/a

-US$269m

Mar 31 2020n/an/a

-US$120m

Dec 31 2019n/an/a

-US$95m

Sep 30 2019n/an/a

-US$71m

Jun 30 2019n/an/a

-US$64m

Mar 31 2019n/an/a

-US$63m

Dec 31 2018US$1mUS$440k

-US$74m

Sep 30 2018n/an/a

-US$77m

Jun 30 2018n/an/a

-US$80m

Mar 31 2018n/an/a

-US$77m

Dec 31 2017US$3mUS$417k

-US$66m

보상 대 시장: Dave 의 총 보상 ($USD 2.72M )은 US 시장( $USD 683.56K ).

보상과 수익: 회사가 수익성이 없는 동안 Dave 의 보상이 증가했습니다.

CEO

Dave Domzalski (57 yo)

4.3yrs

테뉴어

US$2,716,350

보상

Mr. David T. Domzalski, also known as Dave, has been President, Chief Executive Officer and Director at VYNE Therapeutics Inc. (formerly known as Menlo Therapeutics Inc.). since March 9, 2020. Mr. Domzalsk...

리더십 팀

이름위치테뉴어보상소유권
David Domzalski
CEO, President & Director4.3yrsUS$2.72m3.43%
$ 982.2k
Iain Stuart
Chief Scientific Officer4.3yrsUS$1.16m0.92%
$ 263.5k
Mutya Harsch
General Counsel4.3yrsUS$1.13m1.03%
$ 294.1k
Tyler Zeronda
CFO & Treasurer3yrs데이터 없음0.91%
$ 259.5k
Darrell Rigel
Consultant5.6yrsUS$115.20k데이터 없음

4.3yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 관리: VYNE 의 관리팀은 경험 ( 4.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
David Domzalski
CEO, President & Director4.3yrsUS$2.72m3.43%
$ 982.2k
Sharon Surrey-Barbari
Independent Non Employee Director4.3yrsUS$116.10k0.0072%
$ 2.1k
Patrick LePore
Lead Independent Director3.8yrsUS$123.60k0.25%
$ 71.8k
Steven Basta
Director8.8yrsUS$83.60k0.051%
$ 14.7k
Anthony Bruno
Independent Non-Employee Director4.3yrsUS$101.10k0.013%
$ 3.7k
Elisabeth Sandoval-Little
Independent Director5.3yrsUS$108.60k0%
$ 0
Christine Borowski
Independent Directorless than a year데이터 없음데이터 없음
Roy Fleischmann
Member of Scientific Advisory Board2.7yrs데이터 없음데이터 없음
Martin Okun
Member of Scientific Advisory Board2.7yrs데이터 없음데이터 없음
David Sachar
Member of Scientific Advisory Board2.7yrs데이터 없음데이터 없음
Olaf Stuve
Member of Scientific Advisory Board2.7yrs데이터 없음데이터 없음
Johnathan Whetstine
Member of Scientific Advisory Board2.7yrs데이터 없음데이터 없음

3.2yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: VYNE 의 이사회는 경험(평균 재직 기간 3.2 년)으로 간주됩니다.